Results 151 to 160 of about 14,894 (236)

189 EFFECT OF IRON CHELATION THERAPY WITH DEFERASIROX (EXJADE®, ICL670) OR DEFEROXAMINE ON HEPATOCELLULAR INFLAMMATION AND LIVER FUNCTION IN PATIENTS WITH TRANSFUSIONDEPENDENT ANEMIA

, 2008
Yves Deugnier, Bruno Turlin, Madeleine Ropert-Bouchet, B. Rabault, Pierre Brissot   +4 more
openalex   +1 more source

Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major [PDF]

, 2013
Aldo Filosa, Angela Vitrano, Paolo Rigano, Giuseppina Calvaruso, Rita Barone, Marcello Capra, Liana Cuccia, Francesco Gagliardotto, Lorella Pitrolo, Luciano Prossomariti, Maddalena Casale, Vincenzo Caruso, Calogera Gerardi, Saveria Campisi, Paolo Cianciulli, Michele Rizzo, Giuseppe D'Ascola, Angela Ciancio, Aurelio Maggio   +18 more
openalex   +1 more source

Deferoxamine prevents dexamethasone-induced muscle atrophy by reducing MuRF1 and atrogin-1. [PDF]

Front Pharmacol
Jeong JY, Son Y, Kim Y, Lee N, Kim Y, Heo YJ, Choi SE, Choi J, Han SJ, Jeon J, Kim HJ, Lee KW.   +11 more
europepmc   +1 more source

Inflammation and oxidant-stress in -thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial

, 2008
P. B. Walter, Eric A. Macklin, John B. Porter, Patricia Evans, Janet L. Kwiatkowski, Ellis J. Neufeld, Thomas D. Coates, Patricia J. Giardina, Elliott Vichinsky, Nancy F. Olivieri, Daniele Alberti, Jaymes Holland, Paul Harmatz   +12 more
openalex   +2 more sources

Deferoxamine Restores Callus Size, Mineralization, and Mechanical Strength in Fracture Healing after Radiotherapy [PDF]

, 2013
Alexis Donneys, Salman Ahsan, Joseph E. Perosky, Sagar S. Deshpande, Catherine N. Tchanque‐Fossuo, Benjamin Lévi, Ken Kozloff, Steven R. Buchman   +7 more
openalex   +1 more source

Sex and Gender Differences in Iron Chelation. [PDF]

Biomedicines
Allegra S, Comità S, Roetto A, De Francia S.   +3 more
europepmc   +1 more source

Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration. [PDF]

J Clin Med
Pagani A, Thor D, Panayi AC, Klein SM, Geis S, Knoedler L, Knoedler S, Perozzo FAG, Sofo G, Loucas R, Prantl L, Duscher D.   +11 more
europepmc   +1 more source

Deferoxamine, deferasirox, and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a randomised clinical trial. [PDF]

Lancet Reg Health Southeast Asia
Premawardhena A, Wanasinghe S, Perera C, Wijethilaka MN, Rajakaruna RHMG, Samarasinghe RANKK, Williams S, Mettananda S.   +7 more
europepmc   +1 more source

DEFEROXAMINE MIMICS THE PATTERN OF HYPOXIA-RELATED INJURY AT THE MICROVASCULATURE

, 2009
Sonja Bartolome, Navneet K. Dhillon, Shilpa Buch, Alfred J. Casillan, John G. Wood, Amy O’Brien-Ladner   +5 more
openalex   +1 more source

Efficacy of Deferoxamine Mesylate in Serum and Serum-Free Media: Adult Ventral Root Schwann Cell Survival Following Hydrogen Peroxide-Induced Cell Death. [PDF]

Cells
Ma YHE, Putta AR, Chan CHH, Vidman SR, Monje P, Plant GW.   +5 more
europepmc   +1 more source